Oryzon Genomics (STU:ORN) Long-Term Capital Lease Obligation : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oryzon Genomics Long-Term Capital Lease Obligation?

Oryzon Genomics's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil.

Oryzon Genomics's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€0.06 Mil) to Dec. 2023 (€0.06 Mil) and declined from Dec. 2023 (€0.06 Mil) to Mar. 2024 (€0.00 Mil).

Oryzon Genomics's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.08 Mil) but then declined from Dec. 2022 (€0.08 Mil) to Dec. 2023 (€0.06 Mil).

Oryzon Genomics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Oryzon Genomics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oryzon Genomics Long-Term Capital Lease Obligation Chart

Oryzon Genomics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.08

0.06

Oryzon Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.08	0.07	0.06	0.06	-

Oryzon Genomics (STU:ORN) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Oryzon Genomics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Oryzon Genomics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oryzon Genomics (STU:ORN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oryzon Genomics SA (STU:ORN) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ORYZF:USA ORY:Spain

Address

Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940

Website

http://www.oryzon.com

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.